These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15582304)

  • 21. Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide.
    Hackel MA; Karlowsky JA; Dressel D; Sahm DF
    J Clin Microbiol; 2017 Oct; 55(10):3021-3027. PubMed ID: 28747372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.
    Ross JE; Fritsche TR; Sader HS; Jones RN
    Int J Antimicrob Agents; 2007 Mar; 29(3):295-301. PubMed ID: 17239570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sensitivity of bacteria isolated from non-parenteral drugs to antibiotics. II. Sensitivity of gram-positive strains].
    Zembrzuska E
    Acta Pol Pharm; 1981; 38(1):123-8. PubMed ID: 6797259
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The post-antibiotic effects of linezolid against Gram-positive pathogens.
    Hosgor-Limoncu M; Ermertcan S; Tasli H; Aydemir S
    Saudi Med J; 2007 Apr; 28(4):551-4. PubMed ID: 17457476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinone.
    Anderegg TR; Jones RN;
    Diagn Microbiol Infect Dis; 2003 Jan; 45(1):73-6. PubMed ID: 12573554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).
    Jones RN; Fritsche TR; Sader HS; Ross JE
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):309-17. PubMed ID: 17720350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
    Streit JM; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):307-10. PubMed ID: 15922534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
    Sparo MD; Jones DG; Sánchez Bruni SF
    Chemotherapy; 2009; 55(4):270-7. PubMed ID: 19494489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.
    Morrissey I; Colclough A; Northwood J
    Int J Antimicrob Agents; 2007 Oct; 30(4):345-51. PubMed ID: 17643269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic resistant fecal isolates of Enterococci among unselected patients outside the clinical sector: an epidemiological study from Southern Germany.
    Lietzau S; Hoewner M; von Baum H; Marre R; Brenner H
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):275-7. PubMed ID: 16287198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent.
    Rennie RP; Koeth L; Jones RN; Fritsche TR; Knapp CC; Killian SB; Goldstein BP
    J Clin Microbiol; 2007 Oct; 45(10):3151-4. PubMed ID: 17670919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003).
    Johnson DM; Stilwell MG; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):69-74. PubMed ID: 16546341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: results from a global surveillance study (2003-2007).
    Fritsche TR; Sader HS; Stillwell MG; Jones RN
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):440-6. PubMed ID: 19302928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance of linezolid resistance in Germany, 2001-2002.
    Brauers J; Kresken M; Hafner D; Shah PM;
    Clin Microbiol Infect; 2005 Jan; 11(1):39-46. PubMed ID: 15649302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antibacterial activity of nocathiacin I analogues.
    Naidu BN; Sorenson ME; Matiskella JD; Li W; Sausker JB; Zhang Y; Connolly TP; Lam KS; Bronson JJ; Pucci MJ; Yang H; Ueda Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3545-9. PubMed ID: 16621551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis.
    Socha AM; Laplante KL; Russell DJ; Rowley DC
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1504-7. PubMed ID: 19185486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.